The Reduction of both Cyclophilin B and HCV-RNA by the Cyclophilin Inhibitor Debio-025 Confirms the Importance of Cyclophilin B for HCV replication in Man | Debio 025 | /

Home|Careers|Contact us

Welcome

At a glance

Social responsibility

Our companies

Business Model

Development capabilites

News

27.04.2010
Debiopharm Group™ starts Phase I clinical trial with Debio 0932
26.04.2010
Two New Tenants for EPFL’s Innovation Square

The Reduction of both Cyclophilin B and HCV-RNA by the Cyclophilin Inhibitor Debio-025 Confirms the Importance of Cyclophilin B for HCV replication in Man

P. Gallay, R. Flisiak, A. Horban, C. Aeschlimann, J.M. Dumont, H. Porchet, P. Scalfaro, R. Crabbé

42nd Anual Meeting of the European Association for the Study of the Liver - Barcelona/Spain

Abstract + Poster